bioRxivPathologyPreprint
Establishing a preclinical chronic wound model to characterise the pathophysiology of snakebite envenoming
Charlotte A. DawsoniD, Pruistinne HarijantoiD, Yonlada NawilaijaroeniD, Nicholas R. CasewelliD, Jenna L. CashiD
Abstract
Snakebite claims 138,000 lives a year with an additional 400,000 patients left permanently disabled or disfigured1. Morbidity following envenoming includes the development of chronic wounds around the bite site. The understanding of the underlying pathophysiology of chronic snakebite wounds has been severely limited by the historical reliance on a preclinical model that only captures acute local envenoming pathology. Through the application of three medically important snake venoms (Echis ocellatus, Bothrops atrox and Naja nigricollis) to a recently developed preclinical model of chronic wounds, we have been able to characterise key features of venom wounds. We have been able to show that venom wounds share consistencies with non-venom induced preclinical wounds, and also display unique characteristics such as extracellular matrix degradation and eosinophilic infiltrate. This model will not only serve to increase our understanding the underlying pathophysiology of venom wounds, but will also provide a platform for exploring therapeutic interventions to reduce or resolve snakebite wounds.
- research focus: host-pathogen & immune response
- research focus: cell type annotation
- research focus: differential expression
- research focus: cell signaling & trafficking
- approach: experimental assay
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Preclinical validation of a repurposed metal chelator as a community-based therapeutic for hemotoxic snakebite
L.-O. Albulescu, M. Hale, … N. R. Casewell·bioRxiv·Jul 28, 2019
- Machine-learning guided Venom Induced Dermonecrosis Analysis tooL: VIDAL
W. M. Laprade, K. E. Bartlett, … T. P. Jenkins·bioRxiv·May 21, 2023
- Echis carinatus snake venom metalloprotease-induced toxicities in mice: therapeutic intervention by a repurposed drug, tetraethylthiuram disulfide (disulfiram)
G. V. Rudresha, A. P. Urs, … B. Vishwanath·bioRxiv·Jul 17, 2020
- Repurposed drugs and their combinations prevent morbidity-inducing dermonecrosis caused by diverse cytotoxic snake venoms
S. R. Hall, S. A. Rasmussen, … N. R. Casewell·bioRxiv·May 20, 2022
- Dermonecrosis caused by spitting cobra snakebite results from toxin potentiation and is prevented by the repurposed drug varespladib
K. E. Bartlett, S. R. Hall, … N. R. Casewell·bioRxiv·Jul 20, 2023
- Snake Venom Fluidic Properties and Design of Venom Mimics as Rheological Surrogates
Madison Forstner, Matthew L. Holding, … Abdon Pena‐Francesch·bioRxiv·Jun 22, 2026